Massive study aims to perfect testicular cancer aftercare
NCT ID NCT02229916
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 6,900 men treated for testicular cancer to find the best way to detect cancer return and manage long-term side effects. Participants will have regular check-ups using scans, blood tests, and exams. The goal is to create standard follow-up guidelines that catch relapses early while avoiding unnecessary tests and radiation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TESTICULAR NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kantonsspital St.Gallen; Onkologie/Haematologie
RECRUITINGSankt Gallen, 9007, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.